Furthermore, the overexpression of MYBL2 was associated with poor prognosis across various tumor types including ACC, KIRC, BRCA, LGG, KIRP, PAAD, LIHC, THCA, PRAD, and UCEC (Fig. 5B). The gene discussed is MYBL2; the disease is adrenal cortex carcinoma.